News Latest news from the fund and the industry
5 May 2021
Óskare Capital Webinar – The Endocannabinoid System
ÓSKARE CAPITAL's first Webinar focusses on the Endocannabinoid System (ECS) and the science behind the fund’s investment thesis.
9 April 2021
Óskare Capital’s First Portfolio Company, Octarine Bio, Raises $3 Million USD
April 2021
28 January 2021
Guest Post: The Symbiosis of Regulation and Science – Óskare Capital SAS
ÓSKARE Fund I & Medical Cannabinoids
20 January 2021
ÓSKARE CAPITAL STRENGTHENS TEAM AND EXTENDS COVERAGE TO THE AMERICAS BY WELCOMING JD WECHSLER AS VENTURE PARTNER
As we prepare for our first closing in Q1 2021, Óskare Capital is pleased to announce that JD…
14 December 2020
Guest Post: The Cannabis Conversation with Anuj Desai – Interview with Alex Ouimet-Storrs and Bruce Linton of Óskare Capital
Guest Post: The Cannabis Conversation with Anuj Desai - Interview with Alex Ouimet-Storrs and Bruce Linton of Óskare…
7 October 2020
ÓSKARE CAPITAL STRENGTHENS TEAM WITH TWO NEW MEMBERS
Óskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in…
23 July 2020
The Medical Cannabis Opportunity in the EU Stimulus Package
The good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch…
9 July 2020
Broughton bids farewell to Mercia
Mercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund…
9 July 2020
Central Bank signs off on €150m legal cannabis fund
THE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is…